Glucagon Antikörper (AA 19-29)
Kurzübersicht für Glucagon Antikörper (AA 19-29) (ABIN2473807)
Target
Alle Glucagon (GCG) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 19-29
-
Spezifität
- This antibody is specific for the C terminal of Glucagon, a linear peptide of 29 amino acids. Its primary sequence is highly conserved among vertebrates.
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Immunogen
- Glucagon amino acids 19-29, prepared by enzymatic cleavage of Porcine glucagon, conjugated with bovine thyroglobulin carrier protein.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 5.0 mg/mL
-
-
-
Expression of the type I diabetes-associated gene LRP5 in macrophages, vitamin A system cells, and the Islets of Langerhans suggests multiple potential roles in diabetes." in: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, Vol. 48, Issue 10, pp. 1357-68, (2000) (PubMed).
: "
-
Expression of the type I diabetes-associated gene LRP5 in macrophages, vitamin A system cells, and the Islets of Langerhans suggests multiple potential roles in diabetes." in: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, Vol. 48, Issue 10, pp. 1357-68, (2000) (PubMed).
-
- Glucagon (GCG)
-
Andere Bezeichnung
- GLUCAGON
-
Gen-ID
- 2641
-
UniProt
- P01275
-
Pathways
- Positive Regulation of Peptide Hormone Secretion, Peptide Hormone Metabolism, cAMP Metabolic Process, Regulation of Carbohydrate Metabolic Process, Feeding Behaviour, Negative Regulation of intrinsic apoptotic Signaling
Target
-